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Breast cancer is the major cause of tumor-associated mortality in women worldwide, with prognosis depending on the early
discovery of the disease and on the type of breast cancer diagnosed. Among many factors, lipids could contribute to breast
cancer malignancy by participating in cellular processes. Also, aquaporins are membrane channels found aberrantly expressed in
cancer tissues that were correlated with tumor aggressiveness, progression, and metastasis. However, the diﬀerences in lipid
proﬁle and aquaporin expression between cell types of diﬀerent malignant potential have never been investigated. Here, we
selected three breast cancer cell lines representing the three major breast cancer types (hormone positive, HER2NEU positive,
and triple negative) and analyzed their lipid proﬁle and steady state lipid hydroperoxide levels to correlate with cell sensitivity to
H2O2. Additionally, the expression proﬁles of AQP1, AQP3, and AQP5 and the Nrf2 transcription factor were evaluated, before
and after oxidative challenge. We found that the lipid proﬁle was dependent on the cell type, with the HER2-positive cells
having the lowest level PUFA, whereas the triple negative showed the highest. However, in triple-negative cancer cells, a lower
level of the Nrf2 may be responsible for a higher sensitivity to H2O2 challenge. Interestingly, HER2-positive cells showed the
highest increase in intracellular ROS after oxidative challenge, concomitant with a signiﬁcantly higher level of AQP1, AQP3, and
AQP5 expression compared to the other cell types, with AQP3 always being the most expressed isoform. The AQP3 gene
expression was stimulated by H2O2 treatment in hormone-positive and HER2
NEU cells, together with Nrf2 expression, but was
downregulated in triple-negative cells that showed instead upregulation of AQP1 and AQP5. The lipid proﬁle and AQP gene
expression after oxidative challenge of these particularly aggressive cell types may represent metabolic reprogramming of cancer
cells and reﬂect a role in adaptation to stress and therapy resistance.
1. Introduction
Breast cancer is the major cause of tumor-associated mortal-
ity in women worldwide. The prognosis depends on the early
discovery of the disease as well as on the diagnosis. Generally,
breast cancer is grouped into subtypes according to therapy,
in hormone positive (estrogen- and progesterone-positive
tumors) which are treated by hormones, HER2-positive
(positive for the human epidermal growth factor receptor 2
(HER2)) which are treated with trastuzumab, and triple-
negative tumors, which are negative for estrogen, progester-
one, and HER2 receptors and are particularly aggressive, with
a higher propensity for metastasis [1]. Although several
biomarkers and criteria are in place to assist diagnosis and
prognosis after surgery, it is imperative to ﬁnd new markers
and therapeutic targets and to develop new and better
therapies able to bypass tumor adaptation.
Malignant cells commonly have diﬀerent metabolic
requirements than normal cells. Malignant cells tend to rely
on glycolysis and anaerobic metabolism, require increased
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amount of substrates, and are highly dependent on the
movement of water and ions across cell membranes for
the formation of lamellipodia (invadopodia) for cell migra-
tion [2]. Clinical and preclinical studies showed that aqua-
porins (AQPs), membrane channel proteins that mediate
ﬂuxes of water and glycerol and in some cases hydrogen
peroxide (H2O2) across cell membranes [3–7], are aber-
rantly expressed in cancer tissues and positively correlate
with tumor aggressiveness, cancer progression, and metas-
tasis [2, 8, 9]. Overexpression of AQPs was detected in
tumor cells of diﬀerent origins, being associated with tumor
formation, angiogenesis, cell migration, and proliferation,
suggesting that AQPs might be novel targets of diagnostic
and prognostic value and their modulation could be explored
for anticancer treatment [10–13]. In particular, the isoforms
AQP1, AQP3, and AQP5 are abundantly expressed in
diverse tumors and are involved in cell proliferation and
migration by mechanisms that include changes in cellular
shape and enriched ATP production during cell prolifera-
tion and diﬀerentiation [12, 14–18]. In addition, the ability
of AQP3 and AQP5 to facilitate H2O2 diﬀusion through
cell membranes [4, 7] may explain their role in activation
of signaling cascades via H2O2-mediated signaling with
impact in cell proliferation and resistance to oxidative
stress [7, 19, 20].
A few studies have reported the expression of AQPs in
breast cancer, mainly AQP1, AQP3, and AQP5, that were
found higher expressed in tumors than in normal adjacent
tissues [21]. While AQP3 overexpression in early breast
cancer patients was shown to be associated with a worse
prognosis in patients with the HER2-overexpressing pheno-
type [22], AQP1 and AQP5 were reported as independent
prognostic markers of survival for breast cancer patients
[23–25]. In addition, AQP1 overexpression can be induced
by estrogen in a time- and dose-dependent fashion through
activation of the estrogen response element (ERE) motif in
the promoter region of the AQP1 gene, resulting in cell pro-
liferation, migration, invasion, and tubule formation [26].
These data suggest the involvement of AQP1 in estrogen-
induced angiogenesis by stimulation of endothelial cells via
estrogen receptors, resulting in enhancement of tumor cell
migration and invasion [15]. Similarly, the ERE motif was
identiﬁed in the promoter of the AQP3 gene and can be acti-
vated to upregulate the AQP3 expression [27]. Overexpres-
sion of AQP3 was observed in ER-positive breast cancer
tissues obtained from premenopausal patients when com-
pared to those obtained from postmenopausal patients and
is associated with the tumor histological grade and lymph
node metastasis. The role of AQP3 in angiogenesis and
invasion was suggested to involve regulation of the expres-
sion of epithelial-mesenchymal transition (EMT) molecules
and reorganization of actin cytoskeleton, controlling tumor
cell migration and invasion [27]. In addition, AQP3
expression was reported to aﬀect breast cancer cell migra-
tion during metastasis via binding of the chemokine
CXCL12 to its receptor CXCR4 [28]. Signaling via the
CXCL12/CXCR4 axis induces Nox2 activation and extracel-
lular H2O2 production, which is then rapidly transported
intracellularly via AQP3.
Silencing AQP5 in an ER-positive breast cancer cell line
(MCF7) signiﬁcantly reduced cell proliferation and migra-
tion, strongly suggesting that AQP5may play a role in the cell
growth and metastasis of human breast cancer [17]. AQP5
upregulation was closely associated with cellular diﬀerentia-
tion, lymph node invasion, and breast tumor stage [21]. A
signiﬁcant AQP5 upregulation found in tumors from early
breast cancer patients indicates it may be used as a prognostic
marker [24]. Interestingly, AQP5-mediated H2O2 diﬀusion
was demonstrated to modulate cell survival in oxidative
stress conditions [7].
H2O2 is a reactive oxygen species (ROS) that besides
the recognized harmful role acts as an important signaling
molecule in regulation of cellular redox homeostasis [29].
ROS-signaling is attained through reversible oxidation of
thiol residues within proteins, where the intracellular levels
of antioxidant molecules are crucial to maintain the redox
balance. H2O2 regulates the Nrf2 transcription factor, one
of the major antioxidative transcription factors located in
the cytoplasm in complex with Keap1 [30]. Keap1 oxida-
tion by H2O2 activates Nrf2 that translocates to the
nucleus and starts the transcription of antioxidative genes
[30]. Yet, if H2O2 overwhelms the capacity of the cell to
cope with stress, oxidation of all intracellular molecules
occurs. One of the most vulnerable molecules are lipids,
especially their fatty acid moiety, which undergo peroxida-
tion. Polyunsaturated fatty acids (PUFA) are a substrate
for ROS and are prone to peroxidation, leaving a variety
of reactive aldehydes as end products of these reactions
[31]. Among these reactive aldehydes, 4-hydroxynonenal
(HNE), malondialdehyde (MDA), and acrolein are the most
studied. HNE was shown to modulate signaling pathways
and consequently modulate cellular processes leading to pro-
liferation, diﬀerentiation, or apoptosis [32], and interestingly,
it also aﬀects aquaporin activity [33, 34]. As the produced
amount of reactive aldehydes depends on their substrate,
i.e., PUFA, it is not surprising that tumor cells can change
fatty acid content in order to modulate sensitivity to lipid
peroxidation or as a response to the diseased state [35].
Additionally, fatty acids that are a substrate for HNE are
omega6-PUFA, the ones that are substrates for prostaglan-
din production (e.g., arachidonic acid) [36], and therefore,
modulation of the PUFA membrane content may aﬀect
important cellular signaling pathways. Moreover, decreasing
the PUFA content may also aﬀect sensitivity to oxidative
stress and lipid peroxidation.
In this study, we aimed to evaluate the fatty acid content
of breast cancer cell lines of diﬀerent malignancies and corre-
late with the cell sensitivity to oxidative stress. Moreover,
knowing that cell sensitivity to H2O2 largely depends on cell
type and that AQPs are aberrantly expressed inmany tumors,
particularly in the most aggressive, the eﬀect of H2O2 on the
AQP1, AQP3, and AQP5 expression proﬁle was investigated
in breast cancer cell lines representing diﬀerent breast cancer
malignancies, together with their response to oxidative stress
and reaction to the Nrf2 transcription factor. We hypothesize
that variation of expression of speciﬁc AQPs can determine
the cell sensitivity to oxidative stress and may represent a
target for anticancer treatments.
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2. Materials and Methods
2.1. Cell Lines and Culturing Conditions. The following breast
cancer cell lineswere used:MCF7 (estrogen receptor positive),
SkBr3 (HERNEU positive), and SUM159 (triple negative).
Cells were grown in DMEM (Sigma-Aldrich) supplemented
with 10% FCS (fetal calf serum, Sigma-Aldrich) in humidiﬁed
atmosphere with 5% CO2 at 37
°C.
2.2. Treatment. Cells were grown till they reached semicon-
ﬂuency, and after trypsinization, they were counted and
seeded for treatments. For cell viability and ROS assays, cells
were seeded at 1 × 105 cells per well in a 96-well plate, and for
RNA and protein isolation, at a density of 1 × 106 per well in
a 6-well plate. Cells were allowed 24 h to attach and then were
treated with hydrogen peroxide in a range of concentration
for MTT and ROS or with 100 μM H2O2 for RNA and
protein isolation.
2.3. Cell Viability. The cell viability was measured by MTT
EZ4U assay (Biomedica, Austria) according to the manufac-
turer’s instructions. Brieﬂy, 24 h after treatment, cells were
incubated with the colorless solution, which is oxidized in
mitochondria of living cells forming a yellow product, and
the color intensity is measured at 450nm, with 620nm as a
reference wavelength.
2.4. ROS. Intracellular ROS was measured using 2,7-dichlor-
odihydroﬂuorescein diacetate (DCFH-DA, FLUKA, USA).
This nonﬂuorescent dye is deacetylated inside the cells and
after oxidation by intracellular ROS turns ﬂuorescent. Cells
were seeded as described above and left for 24h to attach,
and then they were incubated for 1 h with DCFH-DA. After
removing the excess of the dye, cells were washed once and
were treated with H2O2 in a range of concentrations. Fluores-
cence intensity was measured for 1 h for every 10 minutes in
order to follow the kinetics of H2O2 penetration to the cell.
2.5. RNA Analysis. All three cell lines were trypsinized,
counted, and seeded at 106 cells per well in a 6-well plate
and were allowed for 24 hours to attach to the surface. Next
day, cells were treated with 100 μM H2O2 and were left for
an additional 24 h, after which the cells were lysed in TRI
Reagent (Invitrogen). Total RNA was isolated according to
the manufacturer’s instructions. The total RNA concentra-
tion was determined using a NanoDrop 1000 spectropho-
tometer (NanoDrop Technologies, Wilmington, DE, USA),
and the quality was checked on the agarose gel. cDNA
was obtained from 1 μg of total RNA, and the reverse
transcription was carried out with an oligo dT23 primer
(Sigma-Aldrich) using a MultiScribe Reverse Transcriptase
(Applied Biosystems).
Real-time PCR reactions were carried out using a CFX96
Real-Time System C1000 (Bio-Rad, Hercules, CA, USA), the
TaqMan Universal PCR Master Mix (Applied Biosystems,
Thermo Fisher Scientiﬁc, Waltham, MA, USA), and the
following speciﬁc TaqMan predesigned gene expression
primers: AQP1 (Hs01028916_m1), AQP3 (Hs01105469_g1),
and AQP5 (Hs00387048_m1) (Applied Biosystems). The
relative quantiﬁcation of gene expression was determined
using the 2-ΔCt method (adapted from [37]) with β-actin
as the endogenous control. All samples were run in tripli-
cate and the average values were calculated.
2.6. Fatty Acid Analysis. Cells were treated as described
above, and at the end of treatment, they were trypsinized,
and the dry pellet was stored at -80°C till analysis. Lipids were
isolated according to modiﬁcation of the Folch method [38].
Brieﬂy, 5ml of chloroform was added to the samples and
then mixed thoroughly. An aqueous solution of MgCl2
(1.5ml; 0.034%, w/v) was added to the samples, which were
then vortexed and centrifuged. The upper aqueous phase
was removed, a 2M solution of KCl in methanol (2.5ml;
4 : 1, V/V) was added, and then the samples were vortexed
and centrifuged. The aqueous phase was removed, a chlor-
oform/methanol solution (2.5ml; 2 : 1, V/V) was added, and
then the samples were vortexed and centrifuged. The
hydrophobic phase was collected and transferred to a new
tube, and the solvent was removed by evaporation in the
nitrogen gas stream. Dry residues were stored at -80°C until
further analysis.
To form fatty acid methyl esters, a 0.5M solution of KOH
in methanol [39] was added to the lipid extracts for 10min at
RT. Fatty acid methyl was then extracted with n-hexane and
analyzed by gas chromatography (GC). GC analyses of total
fatty acids were performed by using a Varian 450-GC
equipped with a ﬂame ionization detector. Stabilwax column
(crossbond carbowax polyethylene glycol, 60m × 0 25mm)
was used as a stationary phase with helium as a carrier gas.
The heating was carried out at a temperature of 150°C for
1min followed by an increase of 5°C/min up to 250°C.
The methyl esters were identiﬁed by comparison with the
retention times of commercially available standards.
2.7. Nrf2 Protein Analysis. Cells were grown and treated in
6-well plates as described above. For protein analysis, cells
were harvested in a RIPA buﬀer, and protein concentration
was measured according to Bradford [40]. Aliquots contain-
ing 25 μg protein were separated by SDS-PAGE on 12.5%
resolving gel. Proteins were transferred to the nitrocellulose
membrane (Roti-NC 0.2μm; Carl Roth). The membrane
was blocked with 2% nonfat dry milk, and after removing
the blocking solution, the membrane was incubated with
anti-Nrf2 antibody (Cell Signaling Technology). After wash-
ing, the membrane was incubated with Anti-rabbit IgG,
HRP-linked Antibody (Cell Signaling Technology) (1 : 2000
dilution in blocking buﬀer; CST). Signal was visualized
with a SuperSignal™ West Pico PLUS Chemiluminescent
Substrate (TFS), and the chemiluminescence was detected
using the Alliance 4.7 Digital Imaging System (UVITEC,
Cambridge, UK). Signals were quantiﬁed using the ImageJ
software [41].
2.8. Statistical Analysis. All the experiments were performed
in biological and technical triplicates. Results were expressed
as mean ± SEM of at least three independent experiments.
Statistical analysis between groups was performed by
two-way ANOVA and conﬁrmed by the nonparametric
test Mann–Whitney using the GraphPad Prism software
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(GraphPad Software, La Jolla, CA, USA). p values < 0.05
were considered statistical signiﬁcant.
3. Results and Discussion
Among the risk factors for breast cancer, obesity is certainly
one of the most mentioned, which correlates with the type
of the cancer in pre- or postmenopausal age [42]. These data
indicate the speciﬁc role of lipids in breast cancer malig-
nancy, acting as active participants in cellular processes, such
as arachidonic acid, which is a precursor for prostaglandin
synthesis [36]. In addition, fatty acids, especially polyunsatu-
rated fatty acids (PUFA), are prone to ROS attack resulting in
reactive aldehyde production, which in turn acts as second
messengers of free radicals [31]. In order to investigate
the role of lipids/fatty acids in breast cancer malignancy,
we have selected three breast cancer cell lines representing
the three major breast cancer types: hormone positive
(MCF7), HER2NEU positive (SkBr3), and triple negative
(SUM159). In these cells, we ﬁrst analyzed their lipid pro-
ﬁle and steady state lipid hydroperoxide (LOOH) levels
(Figure 1).
The lipid proﬁle showed that the MCF7 cell line has the
lowest content of saturated fatty acids (SFA), while
SUM159 has the highest (Figure 1(a)). The most prominent
change of individual SFA is C16:0, palmitic acid, which has
the lowest level in SkBr3 cells (Figure 1(c)). Palmitic acid is
a signaling molecule acting through posttranslational modiﬁ-
cations of proteins as on-oﬀ switch of protein activity. In
cancer, palmitic acid enhances proliferation, metastasis, and
invasiveness by stabilizing oncogenic proteins [43]. Lower
levels of palmitic acid in SkBr3 cells could be due to the fact
that its tumorigenity arises from overexpression of the EGF
receptor (HER2NEU), making it hypersensitive to EGF stimu-
lation, which is not aﬀected by palmitoylation. The content of
monounsaturated fatty acids (MUFA) showed an opposing
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Figure 1: Lipid proﬁle and steady state lipid hydroperoxide levels. (a) Composition of total fatty acids (%) of MCF7, SkBr3, and SUM159 cells.
(b) Level of lipid hydroperoxide (LOOH) in MCF7, SkBr3, and SUM159 cells. (c) Speciﬁc analysis of individual fatty acids (%) in MCF7,
SkBr3m and SUM159 cells. ALA: α-linolenic acid. Data are the mean ± SEM of three independent experiments. ∗p < 0 05, ∗∗p < 0 01, and
∗∗∗p < 0 001.
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tendency; while MCF7 had the highest levels, SUM159 had
the lowest levels of MUFA. Similar to SFA, slight but not
signiﬁcant diﬀerences are present between most of the
MUFA, with exception of the oleic acid (C18:1), which is
signiﬁcantly increased in SkBr3 cells compared to MCF7.
Interestingly, oleic acid is decreased in cancer tissues
[44], and treatment of colon cancer cell lines CaCo2 and
HT29-MTX with oleic acid supported the diﬀerentiation
to enterocyte and goblet cell phenotype, respectively [45].
Although HER2NEU-positive tumors are associated with a
more aggressive phenotype, it seems that their lipid
metabolism resembles more like normal cell counterparts,
but this still needs further investigation.
Although elevation of SFA indicates a potential protec-
tive mechanism against oxidative stress, due to lower levels
of the substrate for peroxidation, this was not accompanied
by a decrease in PUFA, as there were no signiﬁcant diﬀer-
ences between the MCF7 and SUM159 cells, while SkBr3
had signiﬁcantly lower levels of these fatty acids (p < 0 05).
Yet, speciﬁc analysis of individual PUFA showed a signif-
icantly higher level of α-linolenic acid (ALA) in SUM159.
ALA is an essential omega3-PUFA, which is used to syn-
thesize eicosapentaenoic acid (EPA, 20:5n-3) and docosa-
hexaenoic acid (DHA, 22:6n-3). ALA is associated with
antitumorigenic eﬀects in mice fed with an ALA-rich diet
[46] and was reported to be toxic for MCF7 cells causing
cell cycle arrest and apoptosis through mitochondrial
membrane depolarization [47]. In MCF7 cells, it was
shown that exogenously added ALA decreased growth via
estrogen receptor-mediated signaling [48]. No doubt that in
cancer cells, metabolic reprogramming occurs and is one of
the hallmarks of cancer. This reprogramming also includes
reprogramming of the lipid metabolism, but it is still uncer-
tain if the changes are due to fatty acid uptake or de novo
synthesis [49]. It was shown that fatty acid content changed
in the red blood cell membrane in cancer patients [50],
indicating that fatty acid content is involved in cancer
growth/development, but the precise role is not clariﬁed. In
the context of ALA, the diﬀerences between cell types of
diﬀerent malignant potential have never been investigated.
The slight diﬀerences observed in MUFA and PUFA con-
tent in the three tested cell lines prompted us to additionally
measure their lipid hydroperoxides (LOOH). LOOH are
intermediate products in peroxidation, and this is the step
that can multiply the lipid peroxidation cascade. Therefore,
we investigated if the slight and nonsigniﬁcant diﬀerences
between the cell lines could be multiplied in this reaction
step. These results showed that SkBr3 cells, a HER2NEU-
positive cell line, had signiﬁcantly higher content of steady
state LOOH (Figure 1(b)). Since this unexpected result did
not correlate with the lower PUFA content in SkBr3
(Figure 1(a)), we proceeded to investigate if the observed
diﬀerences in fatty acid content and LOOH levels in the
steady state could inﬂuence cell sensitivity to H2O2.
Thus, we evaluated cell viability upon H2O2 challenge by
MTT assay (Figure 2). H2O2 is a small molecule produced
intracellularly under physiological conditions in a controlled,
as well as uncontrolled, manner. When H2O2 is produced by
the cell itself, in physiological conditions, it contributes to
redox signaling [29]. Interestingly, the hormone-positive
MCF7 and the HER2NEU-positive SkBr3 cell lines showed
similar sensitivity, while the triple-negative line SUM159
was more sensitive to H2O2 challenge. This diﬀerence in sen-
sitivity cannot be explained by the fatty acid content analysis,
where SUM159 and SkBr3 cells show similar total SFA
content (Figure 1(a)), which is observed in almost every indi-
vidual SFA with exception of C16:0 (Figure 1(c)). SFA do not
contain double bonds that are substrates for ROS attack and
are therefore more resistant to peroxidation [51]. As a conse-
quence, it is supposed that cells with higher SFA content
could be more resistant to oxidative stressors. However, this
is not entirely true, as evidenced by the SkBr3 cell line, which
had the highest LOOH content but showed higher resistance
to H2O2 than SUM159. A possible explanation is that SkBr3
cells may have an adequate antioxidative defense to cope with
the (per)oxidation challenge.
As PUFA content and H2O2 sensitivity did not show cor-
relation, we then investigated if diﬀerences in H2O2 sensitiv-
ity were due to diﬀerences in H2O2 inﬂux between these cell
lines. As the viability curves showed a plateau at 100 μM
H2O2 and above, this was the highest concentration used
for inﬂux measurements. According to the eustress theory,
an extracellular concentration of 100μM H2O2 corresponds
to intracellular 1μM H2O2, which may trigger both eﬀects,
oxidative eustress and distress [52]. Oxidative eustress is a
term for positive low levels of oxidative stress, turning on
adaptive mechanisms without damaging the cells. On the
other hand, distress refers to higher levels of stress leading
to pathological adaptation with cellular damage resulting in
diﬀerent diseases [52]. Which of these eﬀects will occur in a
certain cell line/type depends on the cell gene expression pro-
ﬁle of the antioxidative defense system but also on energy
metabolism; in addition, the expression of AQPs in cell
membranes ﬁne-tuning H2O2 ﬂuxes may also dictate the cell
response to oxidative stress.
Therefore, we ﬁrst analyzed the levels of ROS accumula-
tion after 60 minutes of H2O2 treatment in the three cell lines
(Figure 3(a)). As expected, the most pronounced diﬀerences
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Figure 2: Cell viability upon oxidative stress. Cell viability of MCF7,
SkBr3, and SUM159 cell lines were determined by MTT assay after
exposure to a range of H2O2 concentrations for 24 h. Data are the
mean ± SEM of three independent experiments.
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between ROS levels were found when cells were treated with
100 μM H2O2. Since this concentration induced a signiﬁ-
cantly diﬀerent level of ROS between the three cell lines
and was the maximal inhibitory concentration of cell viability
after 24 h (Figure 2), we followed the rate of ROS accumula-
tion after a challenge with 100μMH2O2. Interestingly, SkBr3
cells showed the highest increase in intracellular ROS, and
SUM159 had the lowest, indicating that this is not the only
factor that accounts for the diﬀerence in sensitivity.
Considering that the antioxidative defense systemmay be
in part responsible for cell resistance to oxidative stress, we
then analyzed the expression of the antioxidant transcription
factor Nrf2 under oxidative stress conditions (Figures 3(c)
and 3(d)). As expected, after exposure to H2O2, the cell lines
MCF7 and SkBr3 increased their Nrf2 levels, in line with the
Nrf2 role in the state of the disturbed cellular redox balance
[30]. On the other hand, for the triple-negative cell line,
SUM159 had levels of Nrf2 lower than those of MCF7 and
SkBr3 that were not changed upon H2O2 treatment. The
lower levels of Nrf2 and the lack of reactivity to H2O2 may
explain the higher sensitivity to H2O2 of SUM159 cells.
Nrf2 targets a variety of antioxidative defense genes including
glutamate-cysteine ligase, catalytic subunit and modiﬁer
subunit (GSH synthesis), thioredoxin reductase 1, peroxire-
doxin 1, Nqo1, and glutathione-S-transferase family [53],
meaning that low levels of Nrf2 consequentially lead to low
levels of antioxidative defense. The failure to increase Nrf2
levels after H2O2 challenge may be due to the inability of its
steady state inhibitor Keap1 to release Nrf2 upon sensing oxi-
dative conditions. When cells are not under oxidative stress,
Nrf2 is in complex with Keap1-Cul3-ubiquitinase E2 com-
plex and is being ubiquitinated for subsequent peroxisomal
degradation [30]. In stress conditions, Keap1 cysteine moie-
ties are oxidized by the stressor, leading to release of Nrf2
and activation of the antioxidative gene transcription. In
SUM159 cells under oxidative stress, lack of Nrf2 response
indicates that this pathway is probably downregulated, caus-
ing increased sensitivity. This result can be considered quite a
paradox, as one would expect that aggressive cancer cells are
more resistant to stress. Still, all three cell lines reach plateau
at 100 μM H2O2, with the lowest value for SUM159. Tumor
cells are followed by a paradox about the role of the ROS
and the use of antioxidants. ROS are one of the factors in can-
cer development, as well as factors in cancer therapy. Antiox-
idants are a factor in cancer prevention but also a factor
which will support tumor growth and counteract tumor
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Figure 3: Antioxidant defense response upon oxidative stress. (a) ROS intracellular accumulation 60 minutes after H2O2 treatment. Cells
were incubated with a range of H2O2 concentrations (10 μM to 100 μM), and ROS accumulation was recorded over 60min. Data was
normalized with basal levels of intracellular ROS. (b) Representative signals of ﬂuorescence output after addition of 100μM H2O2.
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therapy [54]. In this context, prolonged exposure to oxidative
stress could provide an answer in the processes underlying
this initial sensitivity as the aggressiveness is referred to sur-
vival of the small subpopulation of cancer cells which can be
activated under certain conditions and cause recurrence of
the disease. Supporting the paradox of oxidative stress/-
antioxidants is the role of Nrf2 in carcinogenesis. Nrf2 is con-
sidered as a protective factor in the early stage and a
resistance factor in the late stages in cancer development
[30]. Although Nrf2 levels are elevated in certain types of
cancer [30, 55] thereby providing protection against ROS,
its levels in normal tissues are ﬂuctuating and are regulated
by balance between its synthesis and degradation [56].
In order to investigate the inﬂuence of H2O2 inﬂux on the
three breast cancer cell lines, the expression proﬁle of the
three AQP isoforms most expressed in breast cancer tissues,
namely, AQP1, AQP3, and AQP5 [57], was investigated.
The expression analysis revealed that the level of expression
of these AQPs is signiﬁcantly diﬀerent between the three cell
lines, being much higher in the HER2NEU-positive cell line
SkBr3 (Figure 4). The lower basal levels of AQPs expressed
in SUM159 cells compared to the other tested cell lines may
not be easy to understand. It is well accepted that AQPs are
overexpressed in cancer tissues compared to their normal
counterparts and that the overexpression pattern follows
tumor aggressiveness. It is worth mentioning that the tested
cell lines MCF7, SkBr3, and SUM159, although representa-
tive of an increasing level of malignancy, do not derive from
the same primary tumor specimen nor have the same degree
of diﬀerentiation. Knowing that AQPs are tissue- and cell
type-speciﬁc, and that breast cancer is highly heterogeneous,
it is expectable that their basal gene expression level is not
comparable in these three cell lines. In addition, the low levels
or absence of HER2 receptors characteristic of triple-negative
breast cancer cells such as SUM159 may also correlate with
low levels of other membrane proteins such as AQPs. More-
over, the weak basal Nrf2 expression found in these cells may
imply the existence of a complementary protective mecha-
nism to cope with oxidative challenges.
In all the cell lines, AQP3 was the aquaporin most
expressed, followed by lower levels of AQP1 and AQP5. This
result is not surprising, since AQP3 has been reported as an
important player in cancer biology and its expression is
correlated with the epidermal growth factor receptor (EGFR)
in several types of cancer [58].
Interestingly, AQP3 expression was stimulated by H2O2
treatment in MCF7 and in SkBr3 cells and followed the pat-
tern of Nrf2 expression. Yet, unlike MCF7 and SkBr3 cells, in
SUM159 cells, H2O2 treatment downregulated AQP3 expres-
sion, which together with the nonresponsiveness of Nrf2
activation indicates that these cells are intrinsically less
responsive to external oxidative insults and are more prone
to treatment resistance, corroborating their malignant
aggressiveness and metastatic potential.
The mechanism by which AQP3 contributes to cancer
malignancy could be due to regulation of H2O2 inﬂux, which
is enhanced after CXCL12 stimulation in MCF7 cells [28].
A previous study with the epidermoid carcinoma cell line
A-431 showed that AQP3 coprecipitated and colocalized
with EGFR, and its regulation of H2O2 inﬂux was imperative
for EGF/EGFR signaling, including Erk and Akt activation
[19]. Our results show that SkBr3, the HER2NEU-positive cell
line, had the highest level of AQP3 (Figure 4). Interestingly,
recent studies analyzing a panel of breast and ovarian cancer
cell lines [59, 60] showed that SKBR3 cells express the highest
levels of HER2 among all detected cell lines [60], supporting
the above reported relation between EGFR, one of the most
studied HER family receptors and a key oncogenic driver
in many epithelial cancers including breast cancer [61],
and AQP3 expression. In addition, the fact that AQP3 also
transports glycerol that can be used as an energy source in the
glycolytic pathway or as a building unit for phospholipids,
thus contributing to cancer growth, cannot be disregarded.
Regarding AQP1 and AQP5, while in the least malignant
cell line MCF7 their expression decreased after H2O2 treat-
ment, the opposite is observed for the more aggressive SkBr3
and SUM159 cells. The upregulation of AQP gene expression
after H2O2 challenge in these particularly aggressive cell
−H2O2
+H2O2
2500
2000
1500
1000
2.5
2.0
1.5
1.0
0.5
0.0m
RN
A
 re
lat
iv
e e
xp
re
ss
io
n 
×
10
–4
AQP1 AQP3 AQP5
MCF7
⁎
m
RN
A
 re
lat
iv
e e
xp
re
ss
io
n 
×
10
–4
AQP1 AQP3 AQP5
SkBr3
⁎7000
5500
4000
2500
1000
30
20
10
0 m
RN
A
 re
lat
iv
e e
xp
re
ss
io
n 
×
10
–4
AQP1 AQP3 AQP5
SUM159
⁎⁎⁎
350
300
250
200
150
100
50
10
8
6
4
2
0
Figure 4: Eﬀect of H2O2 treatment on aquaporin gene expression. AQP1, AQP3, and AQP5 mRNA expression was determined after treating
cells with 100μM H2O2 for 24 h. Data represent mean ± SEM from three independent experiments. ∗p < 0 05 and ∗∗∗p < 0 001 versus
nontreated cells.
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types may reﬂect their role in adaptation to stress further
contributing to therapy resistance.
In conclusion, breast cancer cells with diﬀerent malig-
nancies show distinct lipid steady state proﬁles and sensitiv-
ity to oxidative stress. Their altered pattern of aquaporin gene
expression triggered by oxidative stress brings evidence to the
involvement of these membrane proteins in cancer aggres-
siveness. Both aquaporins and Nrf2 are important players
in the regulation of normal cellular homeostasis, while their
elevated levels in tumors represent critical factors, which
could contribute to malignancy and therapy resistance. The
interplay of cellular antioxidative defense factors such as
Nrf2 with speciﬁc AQPs in the progression of breast cancer
deserves further investigation.
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